hrp0092p2-167 | GH and IGFs | ESPE2019
Chareca Cinthia D
, Belgorosky Alicia
, Chiarpenello Javier
, Colombi Lia
, Pasqualini Titania
, Von Schulz Hausmann Cristian
, Assefi Aria
, miras mirta
The Easypod Connect Observational Study (ECOS) assessed real-time adherence in patients from 24 countries who were receiving recombinant human growth hormone (r-hGH; Saizen®) via easypod, which is an electronic injection device. Overall, ECOS showed mean adherence was maintained at ~80% for up to 3 years. Here, we assess the adherence to r-hGH administered via easypod in the Argentinian cohort of patients from ECOS (NCT01582334).<p class="ab...